Drs. Riley and Vickery continue their discussion on mental health. Dr. Vickery discusses a recent study reporting newly diagnosed mental illnesses secondary to COVID-19 hospitalization. The discussion then moves to the effects of isolation and

Mental Health: Addressing the Stigma and Whole Person Care

Sep 9th, 2021 30m 53s

Dr. P. Brittany Vickery, a Board Certified Psychiatric Pharmacist, joins Dr. Riley to discuss Mental Health. The conversation begins with a discussion of mental health crises during a pandemic and progresses to a discussion of common struggles

COVID-19: Vaccine Hesitancy, Special Populations, and Mandates

Sep 3rd, 2021 32m 44s

In the final installment of COVID-19 conversation, Drs. Riley and Vickery discuss vaccine hesitancy. The conversation begins with Dr. Riley laying the ground work for including patients in their medical choices. The conversation then progresses

COVID-19: Vaccine Mechanism of Immunogenicity

May 20th, 2021 29m 57s

This episode is a continuation of the previous conversation between Dr. Riley and Dr. Vickery concerning the SARS-CoV-2 vaccinations currently available and in development. The discussion encompasses adverse effect comparative statistics (intro

COVID-19: Drug Repurposing and Vaccine Development

May 13th, 2021 31m 27s

Drs. Riley and Vickery continue their conversation on the COVID-19 pandemic. This time, the conversation is centered on the repurposing of older medications as well as the process of vaccine development.

COVID-19: Inflammation and Therapeutics

May 5th, 2021 36m 22s

Drs. Riley and Vickery continue their discussion of the COVID-19 pandemic. The conversation begins with a recap of risk factors for severe disease and progresses into an intriguing discussion on disease progression and approaches to therapeutic

COVID-19: Risk Factors for Severe Disease

Apr 25th, 2021 35m 49s

Today's guest is Dr. Stephen Vickery, a clinical pharmacist, educator, and infectious disease specialist. We have an evidence-based discussion of COVID-19 and risk factors for severe disease.

Rate